FDA approves second brain imaging drug to help evaluate patients for … – FDA.gov

FDA approves second brain imaging drug to help evaluate patients for …
FDA.gov
FDA approves second brain imaging drug to help evaluate patients for Alzheimer's disease, dementia. The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission …